Patheon,
Inc. (TSX: PTI) has appointed Mark Kontny, Ph.D., as its President of Global
Pharmaceutical Development Services (PDS) and as its Chief Scientific Officer.
Dr. Kontny previously held the position of Division VP, Global Pharmaceutical
and Analytical Sciences for Abbott Laboratories global pharmaceutical research
and development organization.
Top
Best Penny Stocks, a leading financial publication, is pleased to alert
investors of stocks on the move. Sign up for our Free Stock
Newsletter
Patheon
Inc. (TSX: PTI; www.patheon.com) is a leading global provider of contract
development and manufacturing services to the global pharmaceutical industry.
Patheon prides itself in providing the highest quality products and services to
approximately 300 of the world's leading pharmaceutical and biotechnology
companies.
Sign up for Top Best Penny Stocks' free
newsletter. To subscribe, enter your e-mail address into the frame at the
bottom of this press release or visit our website.
Follow
us on Twitter: http://www.Twitter.com/topbestps
About
Us
Top
Best Penny Stocks is a leading stock web site
that allows investors and interested parties to research stocks that are on the
move. We also track small cap companies that are on the brink of a financial
breakout. To feature a company on our web site please contact us at the email
listed below.
Please
click here to read the full disclaimer
